Evaluating the impact of patient-reported outcome measures on depression and anxiety levels in people with multiple sclerosis: a study protocol for a randomized controlled trial

• Published in: BMC neurology Vol. 23; no. 1; p. 53
• Main Authors: Chu, Nathan Y, Watson, Kaitlyn E, Al Hamarneh, Yazid N, Yushko, Lily, Tsuyuki, Ross T, Smyth, Penelope
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.02.2023; BioMed Central; BMC
• Subjects: Anxiety; Anxiety - therapy; Anxiety Disorders; Care and treatment; Chronic illnesses; Clinical outcomes; Clinical trials; Depression; Depression - epidemiology; Depression - etiology; Depression - therapy; Depression, Mental; Diagnosis; Disease; Evaluation; Feasibility studies; HADS; Health care; Hospitals; Humans; Informed consent; Intervention; Mental depression; Mental disorders; Mental health; Methods; Multiple sclerosis; Multiple Sclerosis - complications; Multiple Sclerosis - psychology; Nurse practitioners; Outcome and process assessment (Health Care); Patient Reported Outcome Measures; Patient satisfaction; Patients; Psychological aspects; Quality of life; Questionnaires; Randomized Controlled Trials as Topic; Registration; Research ethics; Study Protocol; Alberta; Alberta Canada; Edmonton Alberta Canada; Canada; Healthcare delivery; Multiple sclerosis; Patient-reported outcome measures; Depression; HADS; Anxiety; Patient satisfaction

Multiple sclerosis (MS) is a chronic disease affecting multiple functional aspects of patients' lives. Depression and anxiety are common amongst persons with MS (PwMS). There has been an interest in utilizing patient-reported outcome measures (PROMs) to capture and systematically assess patient...